Skip to Content

R530 (Divalproex Sodium Delayed-Release 250 mg)

Pill with imprint R530 is White, Elliptical / Oval and has been identified as Divalproex Sodium Delayed-Release 250 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for R530

Divalproex sodium delayed-release 250 mg R530

Divalproex Sodium Delayed-Release

Imprint
R530
Strength
250 mg
Color
White
Size
15.00 mm
Shape
Elliptical / Oval
Availability
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC)
55111-0530
Inactive Ingredients
acetone, hypromellose, hypromellose phthalate (31% phthalate, 40 cst), isopropyl alcohol, methylene chloride, microcrystalline cellulose, povidone, corn starch, silicon dioxide, magnesium silicate, titanium dioxide, vanillin, shellac, ferrosoferric oxide, butyl alcohol, soya lecithin, ferric oxide yellow

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "R530"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.